trial · primary record
NXT007
Hemophilia A
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 138 |
| Primary completion | 2031-09-23 |
| Primary endpoint | Annualized Bleed Rate (ABR) for Treated Bleeds Over the Main Study Treatment Period |
| Registry ID | NCT07416526 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:49.417Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07416526
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.